rs9383589
Variant names:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_025059.4(CCDC170):c.*978A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0698 in 152,188 control chromosomes in the GnomAD database, including 569 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: 𝑓 0.070 ( 569 hom., cov: 32)
Exomes 𝑓: 0.13 ( 0 hom. )
Consequence
CCDC170
NM_025059.4 3_prime_UTR
NM_025059.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.188
Genes affected
CCDC170 (HGNC:21177): (coiled-coil domain containing 170) The function of this gene and its encoded protein is not known. Several genome-wide association studies have implicated the region around this gene to be involved in breast cancer and bone mineral density, but no link to this specific gene has been found. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.291 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC170 | NM_025059.4 | c.*978A>G | 3_prime_UTR_variant | Exon 11 of 11 | ENST00000239374.8 | NP_079335.2 | ||
CCDC170 | XM_011536147.3 | c.*978A>G | 3_prime_UTR_variant | Exon 11 of 11 | XP_011534449.1 | |||
CCDC170 | XM_011536148.3 | c.*978A>G | 3_prime_UTR_variant | Exon 10 of 10 | XP_011534450.1 | |||
CCDC170 | XM_047419372.1 | c.*978A>G | 3_prime_UTR_variant | Exon 10 of 10 | XP_047275328.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0698 AC: 10620AN: 152062Hom.: 570 Cov.: 32
GnomAD3 genomes
AF:
AC:
10620
AN:
152062
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.125 AC: 1AN: 8Hom.: 0 Cov.: 0 AF XY: 0.500 AC XY: 1AN XY: 2
GnomAD4 exome
AF:
AC:
1
AN:
8
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
2
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0698 AC: 10618AN: 152180Hom.: 569 Cov.: 32 AF XY: 0.0688 AC XY: 5119AN XY: 74416
GnomAD4 genome
AF:
AC:
10618
AN:
152180
Hom.:
Cov.:
32
AF XY:
AC XY:
5119
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
556
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Estrogen resistance syndrome Uncertain:1
Mar 01, 2014
Department of Breast and Endocrine Surgery, Kumamoto University
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at